Cannabigerol induces endoplasmic reticulum stress-mediated apoptosis and ferroptosis via the IRE1α-XBP1 axis in human pancreatic cancer cells.
Cannabigerol (CBG), a non-psychoactive phytocannabinoid derived from Cannabis sativa, has attracted increasing attention owing to its antibiotic, anti-inflam...
GLP-1 Receptor Agonist Research Opens New Cancer Era
GLP-1 receptor agonist oncology research is opening new avenues in cancer treatment and metabolic therapy. This emerging field explores tumor suppression and pancreatic cancer links. Clinicians should stay informed about these advances for patient care.
Cannabis Use Disorder and Pancreatic Cancer Risk in Chronic Pancreatitis Patients
Cannabis use disorder research update reveals no significant increase in pancreatic cancer risk among chronic pancreatitis patients. This large multicenter retrospective cohort study provides important insights for clinicians. Understanding cannabis…
Cannabigerol Induces ER Stress-Mediated Apoptosis and Ferroptosis in Pancreatic Cancer
Cannabigerol pancreatic cancer cells research reveals dual mechanisms of cell death: apoptosis and ferroptosis. This study highlights the role of endoplasmic reticulum stress via the IRE1α-XBP1 axis. These findings provide promising preclinical insights…